Skip to main content
The Journal of International Medical Research logoLink to The Journal of International Medical Research
. 2019 Dec 29;48(4):0300060519894437. doi: 10.1177/0300060519894437

Identification of key genes and pathways in abdominal aortic aneurysm by integrated bioinformatics analysis

Yihai Liu 1, Xixi Wang 2, Hongye Wang 1, Tingting Hu 1,
PMCID: PMC7783286  PMID: 31885343

Abstract

Objectives

To identify key genes associated with abdominal aortic aneurysm (AAA) by integrating a microarray profile and a single-cell RNA-seq dataset.

Methods

The microarray profile of GSE7084 and the single-cell RNA-seq dataset were obtained from the Gene Express Omnibus database. Differentially expressed genes (DEGs) were chosen using the R package and annotated by Gene Ontology and Kyoto Encyclopedia of Genes and Genomics analysis. The hub genes were identified based on their degrees of interaction in the protein-protein interaction (PPI) network. Expression of hub genes was determined using single-cell RNA-seq analysis.

Results

In total, 507 upregulated and 842 downregulated DEGs were identified and associated with AAA. The upregulated DEGs were enriched into 9 biological processes and 10 biological pathways, which were closely involved in the pathogenesis and progression of AAA. Based on the PPI network, we focused on six hub genes, four of which were novel target genes compared with the known aneurysm gene database. Using single-cell RNA-seq analysis, we explored the four genes expressed in vascular cells of AAA: CANX, CD44, DAXX, and STAT1.

Conclusions

We identified key genes that may provide insight into the mechanism of AAA pathogenesis and progression and that have potential to be therapeutic targets.

Keywords: Abdominal aortic aneurysm; single-cell RNA-seq; STAT1, CD44; differentially expressed genes; protein–protein interaction

Background

Abdominal aortic aneurysm (AAA) is a degenerative change in the abdominal aorta medial layer caused by various etiologies; the layer dilates to form an aneurysm under blood pressure, leading to permanent dilatation of the arterial wall to more than 150% of the normal vessel diameter. AAA is the tenth leading cause of death in elderly men.1 Epidemiological studies have shown that the incidence of AAA in men increases significantly over the age of 55 years, and the mortality rate is as high as 5.9% in the 80 to 85 year age group.2 Surgical repair, to date, is the main therapeutic regimen, but clinical care is hampered by the lack of etiological treatment (treatment specific to the etiology of an individual case). Therefore, it is of great clinical significance to find new molecular targets involved in initiation and progression of AAA.

AAA is characterized by chronic inflammation, vascular smooth muscle cell apoptosis, and extracellular matrix remodeling and degradation.3 Inflammation is most associated with the progression of AAA.4 Macrophages, located in the media and adventitia, promote the formation of AAA by producing matrix metalloproteinases (MMPs), reactive oxygen species, and inflammatory factors.5 The adventitial mesenchymal cells, including fibroblasts, myofibroblasts, and “synthetic” vascular smooth muscle cells secrete type I collagen and transforming growth factor (TGF)-β, MMPs involved in extracellular matrix (ECM) remodeling.6 Previous studies have identified individual lifestyle factors and physiological parameters associated with the incidence of AAA, such as smoking history and cholesterol levels.7 Recently, a large genome-wide association study meta-analysis identified four new AAA risk loci: SMYD2, LINC00540, MMP9, and ERG.8

Thus, previous studies have focused on revealing the target genes associated with AAA. For example, Zhang et al. predicted AAA target genes by a novel protein–protein interaction (PPI) method.9 However, the cell-specific expression of these hub genes remains to be elucidated. The present study aimed to identify the candidate genes involved in AAA using integrated bioinformatics techniques. We identified differentially expressed genes (DEGs) and then performed enrichment analysis to explore their involved functions and signaling pathways. We discovered hub genes by constructing a PPI network and explored the cell-specific expression of these hub genes. The DEGs may provide insight into the pathogenesis of AAA, which could help elucidate biomarkers and therapeutic targets of AAA.

Materials and methods

Microarray data

The National Center for Biotechnology Information Gene Expression Omnibus database (NCBI-GEO) is a public online database containing many microarray and RNA-seq datasets and from which we obtained two datasets. GSE708410,11 is an mRNA microarray profile based on the GPL570 platform (HG-U133_Plus_2; Affymetrix Human Genome U133 plus 2.0 Array), which consists of 10 control aortic tissues from autopsy and 9 human AAA tissues from patients undergoing surgical procedures. GSE11823712 is a single-cell RNA sequencing profile based on the GPL21103 platform (Illumina HiSeq 4000; Illumina Inc., San Diego, CA, USA), consisting of 3 samples of angiotensin II (AngII)-induced murine AAA tissues. The microarray data of GSE7084 and GSE118237 can be obtained from the NCBI-GEO online database (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi).

The current study protocol was approved by Huaian No. 1 People’s Hospital of Review Board in Huaian on 26 July 2019.

Identification of DEGs

Following sample quality control, DEG analysis was performed using the limma package in R software (http://www.bioconductor.org/packages/release/bioc/html/limma.html). The mRNAs with a P-value <0.05 and |log2 fold-change (FC)| > 1 were considered differentially expressed. Volcano plots, heatmaps, and principal component analysis (PCA) plots were also generated in R (www.r-project.org).

GO and KEGG pathway enrichment analysis

FunRich version 3 (http://www.funrich.org/) was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomics (KEGG) analysis, a common method to annotate genes and explore their biological attributes. Statistically significant biological process terms and biological pathway terms for DEGs were illustrated. Transcription factors (TFs) that might regulate DEGs were also predicted. Based on the cumulative hypergeometric distribution test, P < 0.05 was considered to indicate a statistically significant difference.

PPI network construction and visualization

PPI networks provide valuable information regarding cellular functions and signaling pathways. The online database Search Tool for the Retrieval of Interacting Genes/Proteins13 (http://string-db.org/) was used to search for the interaction of proteins encoded by the identified DEGs. Cytoscape14 (http://cytoscape.org/) was then used to visualize the PPI network, established based on five calculation methods (Degree, EPC, EcCentricity, MCC, and MNC). The intersecting genes calculated from these five algorithms encode core proteins with important biological regulatory functions.

Single-cell analysis of key genes involved in AAA

The single-cell RNA-seq dataset GSE118237 was downloaded from the NCBI-GEO online database. Data analysis was performed using the Loupe Cell Browser software (10x Genomics, Pleasanton, CA, USA) on Cloupe files. The clusters were displayed based on t-distributed stochastic neighbor embedding (t-SNE) projections of the cell transcriptome. Cell types were identified by their expression levels of cell-specific markers.

Results

Identification of DEGs

Using the R limma package, we obtained 507 upregulated DEGs and 842 downregulated DEGs based on the cut-off criteria (P < 0.05 and |log2 FC| > 1). A volcano plot generated in R shows the DEGs with log2 FC scores and –log10 P-value (Figure 1a). The DEGs were clustered between AAA tissues and normal tissues, as shown in the heatmap (Figure 1b). The PCA plot also demonstrated that the DEGs could accurately distinguish AAA samples from non-AAA samples (Figure 1c).

Figure 1.

Figure 1.

(a) Volcano plot of DEGs. Blue dots represented genes with |log2FC| > 1, P < 0.01; red dots represented the rest of the genes (with no significant expression change), (b) Heatmap of DEGs; red represents upregulation and blue represents downregulation in control (Ctl) and AAA tissues and (c) PCA plot of control (Ctl) and AAA tissues. The x- and y-axes denote the variance that each PC accounts for. DEG, differentially expressed gene; FC, fold change; AAA, abdominal aortic aneurysm; PCA, principal component analysis; PC, principal component.

GO and KEGG enrichment analysis

The functions and pathway enrichment of DEGs were analyzed using the Funrich software. As shown in Figure 2a, upregulated DEGs were enriched in signal transduction, cell communication, metabolism, energy pathways, transport, protein metabolism, immune response, apoptosis, and regulation of cell cycle in biological process. They were also involved in TRAIL signaling pathway, proteoglycan syndecan-mediated signaling events, glypican pathway, ErbB receptor signaling pathway, VEGF signaling network, thrombin/protease-activated receptor pathway, plasma membrane estrogen receptor signaling, IFN-gamma pathway, GMCSF mediated signaling events, and Alpha9 beta1 integrin signaling events (Figure 2b). The downregulated DEGs were specifically enriched in muscle contraction, cell growth and maintenance, and aldehyde metabolism in biological process, as well as sphingosine 1-phosphate pathway, class I PI3k signaling events, beta1 integrin cell surface interactions, and Arf6 trafficking events. Finally, we predicted the TF that might regulate our DEGs (Table 1).

Figure 2.

Figure 2.

Bubble plots representing biological processes (a, c) and biological pathways (b, d) of upregulated (a, b) and downregulated (c, d) DEGs. Rich factor indicates the percentage of DEGs divided by all genes within certain GO term. DEG, differentially expressed gene; GO, Gene Ontology.

Table 1.

The predicted TF regulating DEGs.

DEGs TF Number P-value
Upregulated SP4 87 4.82E-02
ASCL2 35 3.48E-02
SOAT1 30 3.96E-02
STAT1 30 3.96E-02
IRF1 21 3.74E-02
POU6F1 20 8.73E-03
ISL2 16 1.55E-02
BARX1 12 3.10E-02
Downregulated SP1 244 1.78E-05
SP4 163 8.45E-06
KLF7 162 4.92E-05
EGR1 121 1.70E-04
HNF4A 105 6.46E-03
NFYA 95 1.28E-03
CTCF 88 2.60E-02
ETS1 84 3.18E-02
MYF5 83 7.47E-06
POU2F1 83 2.27E-03
RREB1 80 2.98E-03
TCF3 79 4.60E-03
MEF2A 78 8.25E-05
NFIC 76 4.35E-03
RFX1 73 4.01E-02
PPARG 71 1.98E-02
JUND 64 1.34E-02
JUNB 64 1.34E-02
FOSB 64 1.34E-02
FOS 64 1.34E-02
JUN 64 1.34E-02
TFAP4 62 1.17E-05
ASCL2 57 8.89E-03
NKX6-1 56 3.87E-03
LHX3 49 4.83E-03
ARID3A 49 8.75E-03
CREB1 47 1.51E-04
NHLH1 44 1.71E-02
HENMT1 44 1.71E-02
PLAU 42 8.77E-03
ATF1 42 8.77E-03
RXRA 41 3.79E-02
NR1H3 38 3.87E-02
HSF1 37 1.87E-03
HNF1A 37 3.12E-03
NR6A1 36 1.54E-03
RARA 35 5.87E-03
RAB40B 35 5.87E-03
GATA1 34 2.14E-03
ZNF238 34 8.80E-03
ZNF513 34 8.80E-03
JDP2 33 7.78E-03
ATF3 33 1.49E-02
FOXA1 33 1.59E-02
FEV 32 2.89E-05
PBX1 29 3.90E-02
PAX6 28 1.83E-03
HOXB4 28 4.35E-02
INSM1 27 5.25E-04
MEIS2 27 1.68E-03
LMO2 27 1.15E-02
SRF 25 1.17E-03
CACD 25 4.79E-03
MAF 24 2.78E-03
GFI1 23 3.43E-02
ONECUT1 23 4.20E-02
PAX7 22 1.11E-02
DBX2 21 5.00E-03
GSC 18 1.90E-02
PRRX1 18 2.39E-02
CDX2 17 7.16E-04
EOMES 17 3.19E-03
FOXC1 15 2.09E-02
PITX3 14 1.61E-02
CEBPD 9 4.16E-03
MAFK 8 2.60E-02
HOXC10 6 2.47E-02

P-value <0.05 was statistically significant.

TF, transcription factor; DEG, differentially expressed gene.

PPI network construction and visualization

All DEGs were submitted to STRING, a biological database and web resource for known and predicted PPI. The PPI network was constructed using Cytoscape software using the settings experiments, neighborhood, database, textmining, and coexpression. After removing isolated genes (those having no interaction with other genes), the upregulated DEGs were displayed with 34 nodes and 36 edges (Figure 3a). According to the degree of each gene, we identified six hub genes with a degree ≥4: AR, CANX, CD44, DAXX, STAT1, and TP53 (Figure 3b). Compared with those in the aneurysm gene database (AGD),15 AR,16 STAT1,17,18 and TP5319 were previously reported to be associated with AAA, whereas CANX, CD44, and DAXX were novel target genes deserving further investigation.

Figure 3.

Figure 3.

(a) The PPI network of upregulated DEGs; red nodes represent hub genes with degree ≥4 and (b) Fold change of each hub gene in AAA compared with normal tissues. PPI, protein-protein interaction; DEG, differentially expressed gene; AAA, abdominal aortic aneurysm.

Single-cell analysis of hub genes involved in AAA

To evaluate the cell-specific expression of our hub genes, we analyzed a single-cell sequencing dataset consisting of three murine AAA tissues using the Loupe Cell Browser software. These cells were clustered into five groups based on k-means clustering and are shown in the t-SNE plot (Figure 4a). The heatmap demonstrated that these clusters differed significantly in transcriptome (Figure 4b). These clusters were mapped to different types of vascular cells based on their highly expressed genes (Table 2). As illustrated by t-SNE plots, CANX was obviously expressed in endothelial cells, smooth muscle cells (SMCs), fibroblasts, and macrophages (Figure 5a). CD44 was mainly expressed in SMCs and a subcluster of fibroblasts (Figure 5b). DAXX and STAT1 were both expressed in some clusters of endothelial cells, SMCs, fibroblasts, and macrophages but their expression levels were relatively low (Figure 5c, 5d). However, AR and TP53 were not detected within any cluster of vascular cells.

Figure 4.

Figure 4.

(a) t-SNE plot of 5 clusters corresponding to different cells types in AAA and (b) Heatmap of highly expressed genes among each cluster. t-SNE, t-distributed stochastic neighbor embedding; AAA, abdominal aortic aneurysm.

Table 2.

Highly expressed genes within different cell types.

Cell type Highly expressed genes Fold change
Fibroblast ANGPTL1 6.52
SFRP4 5.78
DCN 5.73
MMP3 5.71
CLEC3B 5.71
ANGPTL7 5.71
CILP 5.66
CTHRC1 5.61
GDF10 5.34
FBLN1 5.32
Erythroid HBA-A2 7.49
HBA-A1 7.43
HBB-BT 7.15
ALAS2 6.82
HBB-BS 6.80
SNCA 6.73
BPGM 4.75
UBE216 4.10
MKRN1 3.54
CD24A 2.79
Smooth muscle cell SGCG 6.93
KCNMB1 6.71
SUSD5 6.64
MYH11 6.57
PTPRZ1 6.34
NPNT 6.32
SOST 6.31
CNN1 6.29
SYNPO2 6.09
OPTC 6.00
Endothelial cell SOX17 8.67
SOX18 8.64
MMRN1 8.58
PODXL 8.30
BTNL9 8.21
CLDN5 8.16
MMRN2 8.13
CCL21A 8.12
MYCT1 8.04
TMEM88 7.95
Macrophage MZB1 10.52
JCHAIN 9.73
BCL2A1B 9.13
LY86 8.75
CD84 8.72
MS4A6B 8.62
FCGR2B 8.43
MS4A4B 8.36
FCMR 8.36
CD74 8.34

Figure 5.

Figure 5.

The t-SNE plot of expression of CANX (a), CD44 (b), DAXX (c), and STAT1 (d) within all clusters in AAA. t-SNE, t-distributed stochastic neighbor embedding; AAA, abdominal aortic aneurysm.

Discussion

The most significant features of AAA include inflammation and ECM remodeling. The inflammatory cells produce proteinases and MMPs, which promote ECM remodeling by degrading the collagen fibers and elastin. The matrix can then be cleaved into short fragments resembling bioactive chemokines, which recruit immune cells to active the immune response.20 Thus, crosstalk between leukocytes and mesenchymal cells is mediated, establishing an interactive circle of inflammation and ECM remodeling. The current study identified some new candidate genes and signaling pathways closely associated with AAA using an integrated informatics analysis.

The GO and KEGG analyses revealed that the DEGs identified in the current study were enriched in pathways related to inflammation and ECM remodeling. A previous microarray-based expression profiling of AAA and non-aneurysmal tissues revealed that the complement cascade pathway was significantly altered in AAA.10 A recent study demonstrated that DEGs were enriched in proteolysis, inflammation, and apoptotic processes.21 Proteoglycan syndecan-mediated signaling, glypican pathway, and Alpha9 beta1 integrin signaling may be involved in adhesion and signaling conduction between cells and ECM. This aberrant expression of collagens and fibronectins induces myofibroblast transition, activates adhesion molecules, and enhances macrophage infiltration.20 The TRAIL pathway is linked to cell apoptosis and matrix degradation; TRAIL and its receptors show increased expression in AAA, accompanied by vascular calcification.22 Osteoprotegerin (OPG), the TRAIL inhibitor, protects against AAA formation by decreased expression of MMP9 in vascular smooth cells.23 Increased vascular endothelial growth factor (VEGF) and interferon (IFN)-gamma signaling may be attributed to enhanced angiogenesis and transmural macrophage migration.24 The ErbB pathway, also known as epidermal growth factor receptor (EGFR) signaling, plays a role in cell proliferation, differentiation, and survival. Activation of EGFR affects the physiology and pathophysiology of the cardiovascular system. AngII can induce AAA formation by activating ErbB signaling in SMCs mediated by ADAM17, and erlotinib, an EGFR inhibitor, can protect mice from AAA formation induced by AngII.25,26 Inhibition of EGFR activity is emerging as a potential therapeutic strategy to treat AAA.

In accordance with previous reports, some proinflammatory cytokines, chemokines, proteolytic proteins, and aneurysm-related GO entries were identified in the pathogenesis and development of AAA.27,28 By using the emerging single-cell sequencing technique, we further explored the cell-specific expression of these hub genes. The PPI and single-cell sequencing analysis identified four hub genes involved in the progression of AAA. CD44, a polymorphic hyaluronate receptor, may participate in chronic inflammation. The level of CD44 was high and positively correlated with macrophage content in pathological tissues. Proinflammatory factors can induce shedding of CD44 from macrophages, and soluble CD44, in turn, stimulates endothelial cells to secrete interleukin (IL)-1β, enhancing local inflammatory responses.29 Another report confirmed that CD44 was highly expressed in human AAA tissues, based on bioinformatics and quantitative PCR assays.30 In addition, osteopontin was shown to have a pro-autophagy effect on vascular SMCs mediated by the integrin/CD44 pathway.31 In accordance with our t-SNE plot, CD44 was expressed in SMCs and macrophages. These results suggested that CD44 may act on macrophages to enhance inflammation responses and induce loss of SMCs by proapoptotic effects. Meanwhile, the role of CD44-positive T cells in AAA is worth investigating further. CANX encodes a member of the calnexin family. As endoplasmic reticulum-associated proteins, calnexins can, upon binding with calcium, interact with newly synthesized glycoproteins, facilitating protein folding. CANX may participate in regulating endoplasmic reticulum stress and unfolding protein response for cell survival as a universal chaperone.32 CANX also interacts with STAT,33 another hub gene in our study. A report showed that CANX interacted with NOX4, a NADPH oxidase, to form a macromolecule required for maturation and function of NOX4 in the endoplasmic reticulum.34 However, there are no reports about its role in AAA. Based on our results, we speculated that CANX regulates oxidative stress in vascular cells in AAA progression. The signal transducers and activators of transcription (STAT) are a family of TFs associated with numerous cytokines, growth factors, and interferon receptors, including seven members (STAT-1, -2, -3, -4, -5α, -5β, -6). Activation of STAT1 is involved in regulation of apoptosis and matrix remodeling. Increased expression of STAT1 mRNA and protein occurred in AAA tissues, with its highest activity in adventitial inflammatory cells. The expression of STAT1 was also high in peripheral blood cells of AAA. These local and systemic changes indicate that STAT1 is closely associated with AAA.35 Hypoxia and the subsequent inflammation have been shown to induce overexpression of MCP-1 in aortic SMCs, which activate macrophages to secrete IL-6, which in turn promotes aortic SMC apoptosis through STAT1.36 In addition, STAT1 interacts with the toll-like receptor 237 and nuclear factor-kappaB38 signaling pathway to regulate inflammation and vascular remodeling of AAA; in contrast, loss of STAT1 is linked to an increased chance of AAA rupture.17 These reports, combined with our results, suggest that STAT1 has a complex role in AAA that requires further investigation. Another hub gene, DAXX, serves as a histone chaperone and may participate in the epigenetic modification of vascular cells of AAA.39,40 Even though our single cell analysis revealed that DAXX was expressed in all vascular cells, this result must be validated in additional in vitro and in vivo experiments.

Conclusions

By combining a microarray profile and a single-cell RNA-seq dataset of AAA tissues, we identified four hub genes, CANX, CD44, STAT1, and DAXX, and some signaling pathways closely related to AAA. These key genes provide insight into the mechanism of AAA initiation and progression and thus are potential therapeutic targets for AAA.

Acknowledgements

We are grateful to all researchers who contributed to the shared GSE datasets.

Authors’ contributions

YH Liu analyzed the data and wrote the manuscript; HY Wang performed the experiments; XX Wang analyzed the data; TT Hu reviewed the research program and designed the experiment.

Declaration of conflicting interest

The authors declare that there is no conflict of interest.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

ORCID iD

Yihai Liu https://orcid.org/0000-0001-5404-5931

References

  • 1.Anderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep 2002; 50: 1–85. [PubMed] [Google Scholar]
  • 2.Bengtsson H, Sonesson B, Bergqvist D. Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann N Y Acad Sci 1996; 800: 1–24. [DOI] [PubMed] [Google Scholar]
  • 3.Aggarwal S, Qamar A, Sharma Vet al. Abdominal aortic aneurysm: a comprehensive review. Exp Clin Cardiol 2011; 16: 11–15. [PMC free article] [PubMed] [Google Scholar]
  • 4.Ailawadi G, Eliason JL, Upchurch GR., Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 2003; 38: 584–588. [DOI] [PubMed] [Google Scholar]
  • 5.Davis FM, Rateri DL, Daugherty A. Abdominal aortic aneurysm: novel mechanisms and therapies. Curr Opin Cardiol 2015; 30: 566–573. DOI: 10.1097/HCO.0000000000000216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ijaz T, Sun H, Pinchuk IVet al. Deletion of NF-kappaB/RelA in angiotensin II-sensitive mesenchymal cells blocks aortic vascular inflammation and abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2017; 37: 1881–1890. DOI: 10.1161/ATVBAHA.117.309863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Stackelberg O, Wolk A, Eliasson Ket al. Lifestyle and risk of screening-detected abdominal aortic aneurysm in men. J Am Heart Assoc 2017; 6: pii: e004725. DOI: 10.1161/JAHA.116.004725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jones GT, Tromp G, Kuivaniemi Het al. Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci. Circ Res 2017; 120: 341–353. DOI: 10.1161/CIRCRESAHA.116.308765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang K, Li T, Fu Yet al. Predicting abdominal aortic aneurysm target genes by level-2 protein-protein interaction. PLoS One 2015; 10: e0140888. DOI: 10.1371/journal.pone.0140888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hinterseher I, Erdman R, Donoso LAet al. Role of complement cascade in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2011; 31: 1653–1660. DOI: 10.1161/ATVBAHA.111.227652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lenk GM, Tromp G, Weinsheimer Set al. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007; 8: 237. DOI: 10.1186/1471-2164-8-237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hadi T, Boytard L, Silvestro Met al. Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells. Nat Commun 2018; 9: 5022. DOI: 10.1038/s41467-018-07495-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Franceschini A, Szklarczyk D, Frankild Set al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41: D808–D815. DOI: 10.1093/nar/gks1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Shannon P, Markiel A, Ozier Oet al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504. DOI: 10.1101/gr.1239303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sun R, Cui C, Zhou Yet al. AGD: Aneurysm Gene Database. Database (Oxford) 2018; 2018: 1–6. DOI: 10.1093/database/bay100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Davis JP, Salmon M, Pope NHet al. Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation. J Vasc Surg 2016; 63: 1602–1612.e2. DOI: 10.1016/j.jvs.2015.11.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Eagleton MJ, Xu J, Liao Met al. Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation. J Vasc Surg 2010; 51: 951–961; discussion 961. DOI: 10.1016/j.jvs.2009.11.075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tanimura M, Dohi K, Hirayama Met al. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation. Int J Cardiol 2015; 196: 88–90. DOI: 10.1016/j.ijcard.2015.05.183. [DOI] [PubMed] [Google Scholar]
  • 19.Li L, Sima X, Bai Pet al. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm. Clin Dev Immunol 2012; 2012: 567586. DOI: 10.1155/2012/567586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol 2010; 10: 712–723. DOI: 10.1038/nri2852. [DOI] [PubMed] [Google Scholar]
  • 21.Butt HZ, Sylvius N, Salem MKet al. Microarray-based gene expression profiling of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2016; 52: 47–55. DOI: 10.1016/j.ejvs.2016.03.016. [DOI] [PubMed] [Google Scholar]
  • 22.Liu X, Winrow VR, Horrocks Met al. Differential expression of TRAIL and its receptors relative to calcification in AAA. Biochem Biophys Res Commun 2007; 358: 18–23. DOI: 10.1016/j.bbrc.2007.03.209. [DOI] [PubMed] [Google Scholar]
  • 23.Bumdelger B, Kokubo H, Kamata Ret al. Osteoprotegerin prevents development of abdominal aortic aneurysms. PLoS One 2016; 11: e0147088. DOI: 10.1371/journal.pone.0147088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sano M, Sasaki T, Hirakawa Set al. Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm. PLoS One 2014; 9: e89830. DOI: 10.1371/journal.pone.0089830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Obama T, Tsuji T, Kobayashi Tet al. Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model. Clin Sci (Lond) 2015; 128: 559–565. DOI: 10.1042/CS20140696. [DOI] [PubMed] [Google Scholar]
  • 26.Kawai T, Takayanagi T, Forrester SJet al. Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) is required for angiotensin II/beta-aminopropionitrile-induced abdominal aortic aneurysm. Hypertension 2017; 70: 959–963. DOI: 10.1161/HYPERTENSIONAHA.117.09822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yuwen L, Ciqiu Y, Yi Set al. A pilot study of protein microarray for simultaneous analysis of 274 cytokines between abdominal aortic aneurysm and normal aorta. Angiology 2019; 70: 830–837. DOI: 10.1177/0003319719844678. [DOI] [PubMed] [Google Scholar]
  • 28.Yang P, Cai Z, Wu Ket al. Identification of key microRNAs and genes associated with abdominal aortic aneurysm based on the gene expression profile. Experimental Physiology 2019; 104: 1–39. DOI: 10.1113/EP087705. [DOI] [PubMed] [Google Scholar]
  • 29.Krettek A, Sukhova GK, Schonbeck Uet al. Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells. Am J Pathol 2004; 165: 1571–1581. DOI: 10.1016/S0002-9440(10)63414-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Biros E, Moran CS, Rush CMet al. Differential gene expression in the proximal neck of human abdominal aortic aneurysm. Atherosclerosis 2014; 233: 211–218. DOI: 10.1016/j.atherosclerosis.2013.12.017. [DOI] [PubMed] [Google Scholar]
  • 31.Zheng YH, Tian C, Meng Yet al. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J Cell Physiol 2012; 227: 127–135. DOI: 10.1002/jcp.22709. [DOI] [PubMed] [Google Scholar]
  • 32.Ryan D, Carberry S, Murphy ACet al. Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. J Transl Med 2016; 14: 196. DOI: 10.1186/s12967-016-0948-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lakkaraju AK, van der Goot FG. Calnexin controls the STAT3-mediated transcriptional response to EGF. Mol Cell 2013; 51: 386–396. DOI: 10.1016/j.molcel.2013.07.009. [DOI] [PubMed] [Google Scholar]
  • 34.Prior KK, Wittig I, Leisegang MSet al. The endoplasmic reticulum chaperone calnexin is a NADPH oxidase NOX4 interacting protein. J Biol Chem 2016; 291: 7045–7059. DOI: 10.1074/jbc.M115.710772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Liao M, Xu J, Clair AJet al. Local and systemic alterations in signal transducers and activators of transcription (STAT) associated with human abdominal aortic aneurysms. J Surg Res 2012; 176: 321–328. DOI: 10.1016/j.jss.2011.05.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Fang L, Moore XL, Dart AMet al. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol 2015; 12: 305–312. DOI: 10.11909/j.issn.1671-5411.2015.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yan H, Cui B, Zhang Xet al. Antagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm. Acta Pharm Sin B 2015; 5: 176–187. DOI: 10.1016/j.apsb.2015.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Liang ES, Cheng W, Yang RXet al. Peptidyl-prolyl isomerase Pin1 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in ApoE(-/-) mice. J Mol Cell Cardiol 2018; 114: 334–344. DOI: 10.1016/j.yjmcc.2017.12.006. [DOI] [PubMed] [Google Scholar]
  • 39.Hoelper D, Huang H, Jain AYet al. Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX. Nat Commun 2017; 8: 1193. DOI: 10.1038/s41467-017-01206-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Voon HP, Wong LH. New players in heterochromatin silencing: histone variant H3.3 and the ATRX/DAXX chaperone. Nucleic Acids Res 2016; 44: 1496–1501. DOI: 10.1093/nar/gkw012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of International Medical Research are provided here courtesy of SAGE Publications

RESOURCES